Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Folia Morphol (Warsz) ; 79(1): 113-119, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-31063201

RESUMEN

BACKGROUND: Many traditional treatments have been recommended in the alternative system of medicine for the treatment of diabetes mellitus. The aim of this study was to assess oxidative stress and histological changes in the pancreas of alloxan-induced diabetic rats following Myristica fragrans seed (nutmeg) extract treatment. MATERIALS AND METHODS: Forty-eight male Wistar rats weighing 200-250 g were randomly divided into six groups of 8 rats each - group I, non-diabetic rats; group II, diabetic rats; groups III, IV and V, diabetic rats given orally nutmeg extract at levels of 50, 100 and 200 mg/kg, respectively; and group VI, diabetic rats given orally metformin (100 mg/kg). The experiment lasted for 28 days. RESULTS: Data showed that nutmeg extract (100 and 200 mg/kg) significantly decreased the blood glucose levels and increased the levels of serum insulin in diabetic rats. Administration of nutmeg extract to diabetic rats reduced oxidative stress and improved the antioxidant activities in pancreatic tissue. Histopathologic results of treated groups revealed marked improvement in the morphology of the pancreas compared with the control diabetic group. In addition, number of pancreatic islets and per cent of ß-cells increased significantly in these groups in comparison with diabetic untreated group. CONCLUSIONS: These results suggest that nutmeg extract has potent antidiabetic and ß-cell protection activities in alloxan induced diabetic rats, possibly via its antioxidant properties.


Asunto(s)
Diabetes Mellitus Experimental/patología , Myristica , Estrés Oxidativo/efectos de los fármacos , Páncreas/efectos de los fármacos , Extractos Vegetales/farmacología , Aloxano/toxicidad , Animales , Glucemia/efectos de los fármacos , Diabetes Mellitus Tipo 1/patología , Masculino , Páncreas/patología , Ratas , Ratas Wistar
2.
Bratisl Lek Listy ; 113(8): 495-7, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22897375

RESUMEN

OBJECTIVE: To compare the frequency of celiac disease (CD) in patients with multiple sclerosis (MS) and healthy controls using tissue transglutaminase IgA antibodies (anti-tTGA) as a screening tool. BACKGROUND: CD and MS are immune-mediated diseases, and it has been hypothesized that the genetic similarities between these conditions can predispose individuals to suffer from both. Data regarding this association are limited, particularly in Eastern countries. METHODS: One hundred clinically defined MS patients were randomly selected from Tabriz, northwest of Iran. The control group consisted of 121 age- and gender-matched healthy individuals. All subjects were screened with anti-tTGA. Total IgA was obtained for investigation of IgA deficiency. RESULTS: The mean age of MS patients (32 male and 68 female) was 33.06±8.79 years; the mean age of controls was 32.98±9.62 years. The mean expanded disability scale score (EDSS) for MS patients was 3.86±1.91. Approximately 78.5 % of MS patients suffered from a remitting relapsing type of MS. All subjects (MS patients and controls) were negative for anti-tTGA. IgA deficiency was demonstrated in 14 % of MS patients and 11 % of controls (p>0.1). No IgA-deficient subjects consented to undergo a duodenal mucosa biopsy. CONCLUSION: The present study failed to demonstrate a positive relationship between MS and CD. Therefore, we conclude that there is no basis for recommending the routine screening of MS sufferers for celiac disease (Ref. 23).


Asunto(s)
Enfermedad Celíaca/complicaciones , Esclerosis Múltiple/complicaciones , Adulto , Enfermedad Celíaca/epidemiología , Enfermedad Celíaca/inmunología , Femenino , Humanos , Inmunoglobulina A/análisis , Irán/epidemiología , Masculino , Esclerosis Múltiple/epidemiología , Esclerosis Múltiple/inmunología , Transglutaminasas/inmunología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...